Beximco Pharmaceuticals Limited (BXP.L)
GBp 38.0
(1.33%)
GBp 38.0
(1.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 2.55 Billion BDT | -26.15% |
| 2021 | 3.45 Billion BDT | 186.25% |
| 2020 | 1.2 Billion BDT | -26.94% |
| 2019 | 1.65 Billion BDT | -36.37% |
| 2018 | 2.59 Billion BDT | -35.39% |
| 2017 | 4.01 Billion BDT | 52.41% |
| 2016 | 2.63 Billion BDT | 187.47% |
| 2015 | 916.92 Million BDT | 1.69% |
| 2014 | 901.7 Million BDT | -21.69% |
| 2013 | 1.15 Billion BDT | -21.65% |
| 2012 | 1.46 Billion BDT | -22.24% |
| 2011 | 1.89 Billion BDT | -0.64% |
| 2010 | 1.9 Billion BDT | -1.18% |
| 2009 | 1.92 Billion BDT | 33.06% |
| 2008 | 1.44 Billion BDT | -18.57% |
| 2007 | 1.77 Billion BDT | 53.23% |
| 2006 | 1.15 Billion BDT | -16.44% |
| 2005 | 1.38 Billion BDT | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 1.6 Billion BDT | -11.7% |
| 2023 Q1 | 2.3 Billion BDT | -9.57% |
| 2023 Q2 | 1.81 Billion BDT | -21.26% |
| 2022 Q2 | 3.22 Billion BDT | -2.81% |
| 2022 FY | 2.55 Billion BDT | -26.15% |
| 2022 Q4 | 2.55 Billion BDT | -16.56% |
| 2022 Q3 | 3.05 Billion BDT | -5.35% |
| 2022 Q1 | 3.32 Billion BDT | -3.79% |
| 2021 Q2 | 4.22 Billion BDT | -3.94% |
| 2021 Q3 | 3.71 Billion BDT | -12.22% |
| 2021 Q4 | 3.45 Billion BDT | -6.97% |
| 2021 FY | 3.45 Billion BDT | 186.25% |
| 2021 Q1 | 4.4 Billion BDT | 264.91% |
| 2020 Q4 | 1.2 Billion BDT | 5.93% |
| 2020 Q3 | 1.13 Billion BDT | -19.11% |
| 2020 Q2 | 1.4 Billion BDT | 0.85% |
| 2020 Q1 | 1.39 Billion BDT | -15.45% |
| 2020 FY | 1.2 Billion BDT | -26.94% |
| 2019 Q2 | 1.9 Billion BDT | -6.29% |
| 2019 Q1 | 2.03 Billion BDT | -21.78% |
| 2019 Q4 | 1.65 Billion BDT | -6.86% |
| 2019 Q3 | 1.77 Billion BDT | -6.79% |
| 2019 FY | 1.65 Billion BDT | -36.37% |
| 2018 Q2 | 3.26 Billion BDT | -1.66% |
| 2018 Q1 | 3.31 Billion BDT | -17.48% |
| 2018 Q4 | 2.59 Billion BDT | -2.8% |
| 2018 FY | 2.59 Billion BDT | -35.39% |
| 2018 Q3 | 2.67 Billion BDT | -18.1% |
| 2017 Q3 | 4.65 Billion BDT | 30.71% |
| 2017 Q2 | 3.55 Billion BDT | 31.83% |
| 2017 Q1 | 2.7 Billion BDT | 2.44% |
| 2017 FY | 4.01 Billion BDT | 52.41% |
| 2017 Q4 | 4.01 Billion BDT | -13.65% |
| 2016 Q4 | 2.63 Billion BDT | -2.41% |
| 2016 Q2 | 2.25 Billion BDT | -0.61% |
| 2016 Q3 | 2.7 Billion BDT | 19.86% |
| 2016 Q1 | 2.26 Billion BDT | -4.16% |
| 2016 FY | 2.63 Billion BDT | 187.47% |
| 2015 Q4 | 2.36 Billion BDT | 0.0% |
| 2015 Q1 | 1 Billion BDT | 54.29% |
| 2015 FY | 916.92 Million BDT | 1.69% |
| 2015 Q2 | 916.92 Million BDT | -9.12% |
| 2014 Q4 | 653.95 Million BDT | -15.28% |
| 2014 Q3 | 771.88 Million BDT | -14.4% |
| 2014 Q2 | 901.7 Million BDT | -1.47% |
| 2014 Q1 | 915.2 Million BDT | -12.58% |
| 2014 FY | 901.7 Million BDT | -21.69% |
| 2013 Q1 | 1.24 Billion BDT | -3.03% |
| 2013 Q2 | 1.15 Billion BDT | -7.54% |
| 2013 Q3 | 1 Billion BDT | -12.92% |
| 2013 Q4 | 1.04 Billion BDT | 4.42% |
| 2013 FY | 1.15 Billion BDT | -21.65% |
| 2012 Q1 | 1.62 Billion BDT | 0.0% |
| 2012 Q3 | 1.43 Billion BDT | -2.69% |
| 2012 FY | 1.46 Billion BDT | -22.24% |
| 2012 Q4 | 1.28 Billion BDT | -10.2% |
| 2012 Q2 | 1.46 Billion BDT | -9.79% |
| 2011 Q2 | 1.89 Billion BDT | 3.02% |
| 2011 FY | 1.89 Billion BDT | -0.64% |
| 2011 Q1 | 1.83 Billion BDT | -0.52% |
| 2010 Q4 | 1.84 Billion BDT | -3.97% |
| 2010 Q1 | 1.93 Billion BDT | 0.59% |
| 2010 Q2 | 1.9 Billion BDT | -1.77% |
| 2010 Q3 | 1.92 Billion BDT | 0.95% |
| 2010 FY | 1.9 Billion BDT | -1.18% |
| 2009 Q1 | 2.25 Billion BDT | 19.65% |
| 2009 Q4 | 1.92 Billion BDT | -1.81% |
| 2009 Q3 | 1.96 Billion BDT | 1.86% |
| 2009 Q2 | 1.92 Billion BDT | -14.5% |
| 2009 FY | 1.92 Billion BDT | 33.06% |
| 2008 Q2 | 1.44 Billion BDT | 0.0% |
| 2008 Q4 | 1.88 Billion BDT | 0.0% |
| 2008 FY | 1.44 Billion BDT | -18.57% |
| 2007 Q2 | 1.77 Billion BDT | 0.0% |
| 2007 FY | 1.77 Billion BDT | 53.23% |
| 2007 Q4 | 1.57 Billion BDT | 0.0% |
| 2006 FY | 1.15 Billion BDT | -16.44% |
| 2005 FY | 1.38 Billion BDT | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|